Growth Metrics

Steris (STE) EBIAT (2018 - 2025)

Steris has reported EBIAT over the past 8 years, most recently at $194.3 million for Q4 2025.

  • For Q4 2025, EBIAT rose 11.99% year-over-year to $194.3 million; the TTM value through Dec 2025 reached $715.6 million, up 52.54%, while the annual FY2025 figure was $616.1 million, 62.88% up from the prior year.
  • EBIAT for Q4 2025 was $194.3 million at Steris, up from $191.9 million in the prior quarter.
  • Over five years, EBIAT peaked at $194.3 million in Q4 2025 and troughed at -$315.2 million in Q3 2022.
  • A 5-year average of $100.2 million and a median of $135.7 million in 2023 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: crashed 551.55% in 2022 and later surged 15207.19% in 2025.
  • Year by year, EBIAT stood at $143.1 million in 2021, then decreased by 13.82% to $123.3 million in 2022, then increased by 14.12% to $140.7 million in 2023, then grew by 23.27% to $173.5 million in 2024, then grew by 11.99% to $194.3 million in 2025.
  • Business Quant data shows EBIAT for STE at $194.3 million in Q4 2025, $191.9 million in Q3 2025, and $178.0 million in Q2 2025.